Stonepine Capital Management as of Dec. 31, 2018
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 22 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 13.2 | $15M | 1.1M | 13.61 | |
| BioDelivery Sciences International | 12.9 | $15M | 4.0M | 3.70 | |
| BioSpecifics Technologies | 11.6 | $13M | 217k | 60.60 | |
| Cumberland Pharmaceuticals (CPIX) | 7.0 | $7.9M | 1.3M | 6.03 | |
| Apollo Endosurgery | 6.6 | $7.5M | 2.2M | 3.45 | |
| Neos Therapeutics | 6.1 | $6.9M | 4.2M | 1.65 | |
| Htg Molecular Diagnostics | 6.0 | $6.8M | 2.7M | 2.54 | |
| Vanda Pharmaceuticals (VNDA) | 5.1 | $5.8M | 221k | 26.13 | |
| Opiant Pharmaceuticals | 4.5 | $5.2M | 358k | 14.45 | |
| Ophthotech | 4.3 | $4.9M | 4.1M | 1.20 | |
| Alimera Sciences | 4.1 | $4.7M | 6.5M | 0.72 | |
| Foamix Pharmaceuticals | 4.1 | $4.6M | 1.3M | 3.59 | |
| Cti Biopharma | 3.7 | $4.2M | 5.7M | 0.73 | |
| Viveve Med | 3.1 | $3.6M | 3.4M | 1.05 | |
| Oxford Immunotec Global | 2.5 | $2.8M | 222k | 12.78 | |
| Affimed Therapeutics B V | 1.9 | $2.2M | 714k | 3.11 | |
| Correvio Pharma Corp | 0.9 | $1.1M | 424k | 2.49 | |
| Chembio Diagnostics | 0.7 | $832k | 147k | 5.66 | |
| Alphatec Holdings (ATEC) | 0.7 | $775k | 338k | 2.29 | |
| Molecular Templates | 0.4 | $463k | 115k | 4.04 | |
| Noveliontherapeuti.. | 0.4 | $447k | 532k | 0.84 | |
| Catabasis Pharmaceuticals Ord | 0.2 | $182k | 42k | 4.37 |
